TriSalus Life Sciences (TLSI) Stock Forecast & Price Target

$3.94 +0.13 (+3.41%)

(As of 09:34 AM ET)

TriSalus Life Sciences - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 9 Analyst Ratings

Sell
0

Hold
0

Buy
9

Based on 9 Wall Street analysts who have issued ratings for TriSalus Life Sciences in the last 12 months, the stock has a consensus rating of "Buy." Out of the 9 analysts, 7 have given a buy rating, and 2 have given a strong buy rating for TLSI.

Consensus Price Target

$11.79
199.13% Upside

According to the 9 analysts' twelve-month price targets for TriSalus Life Sciences, the average price target is $11.79. The highest price target for TLSI is $16.00, while the lowest price target for TLSI is $10.00. The average price target represents a forecasted upside of 199.13% from the current price of $3.94.

Get the Latest News and Ratings for TLSI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for TriSalus Life Sciences and its competitors.

TLSI Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	7 Buy rating(s)	6 Buy rating(s)	4 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$11.79	$12.08	$12.50	N/A
Forecasted Upside	199.13% Upside	229.25% Upside	172.33% Upside	N/A
Consensus Rating	Buy	Buy	Buy	N/A

Will the Nasdaq 100 crash? (Ad)

In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!

Click here to get the details.

TLSI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TLSI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

TriSalus Life Sciences Stock vs. The Competition

Type	TriSalus Life Sciences	Medical Companies	S&P 500
Consensus Rating Score	3.22	2.81	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	209.34% Upside	28,526.48% Upside	12.04% Upside
News Sentiment Rating	Positive News See Recent TLSI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	Cantor Fitzgerald 3 of 5 stars	R. Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$10.00	+157.73%
11/15/2024	Canaccord Genuity Group 1 of 5 stars		Lower Target	Buy ➝ Buy	$12.00 ➝ $11.00	+174.31%
11/11/2024	Roth Capital 2 of 5 stars	J. Wittes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
11/11/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$11.00	+160.05%
10/25/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Byrnes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
10/25/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$12.50	+204.14%
9/16/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$10.00	+121.24%
5/10/2024	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$16.00	+60.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:24 AM ET.

TLSI Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for TriSalus Life Sciences is $11.79, with a high forecast of $16.00 and a low forecast of $10.00.
: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TriSalus Life Sciences in the last twelve months. There are currently 7 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TLSI shares.
: According to analysts, TriSalus Life Sciences's stock has a predicted upside of 199.13% based on their 12-month stock forecasts.
: Over the previous 90 days, TriSalus Life Sciences's stock had 2 upgrades by analysts.
: TriSalus Life Sciences has been rated by research analysts at Canaccord Genuity Group, Cantor Fitzgerald, Northland Capmk, Northland Securities, Roth Capital, and Roth Mkm in the past 90 days.
: Analysts like TriSalus Life Sciences more than other "medical" companies. The consensus rating for TriSalus Life Sciences is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TLSI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Will the Nasdaq 100 crash? (Ad)

Click here to get the details.

This page (NASDAQ:TLSI) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TriSalus Life Sciences (TLSI) Stock Forecast & Price Target